Revvity Inc vs Williams Companies Inc — how do they compare? Revvity Inc trades at $124.14 (market cap $13.82B), while Williams Companies Inc trades at $75.31 (market cap $91.92B). The key difference: Williams Companies Inc is far larger — about 6.7× Revvity Inc's market cap, and Williams Companies Inc pays the higher dividend (2.79%). Which is the better fit depends on your goals.
| RVTY | WMB | |
|---|---|---|
Market Cap | $13.82B | $91.92B |
Sector | Technology | Energy |
52-Week High | $130.94 | $79.40 |
52-Week Low | $82.26 | $56.51 |
Enterprise Value | $16.14B | $122.55B |
Dividend Yield | 0.23% | 2.79% |
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $127.08, down 2.41% on the day, with a bullish technical signal from moving averages and strong support at $126. The company reported Q2 2026 EPS of $1.41, beating estimates, and raised its full-year outlook, driven by diagnostics strength and improved cash flow. Recent news includes the acquisition of Human Cell Design and the launch of the SuperFlex prenatal screening system.
Outlook is positive with 52% analyst buy ratings and a $135.25 consensus price target, implying ~6% upside. Risks include a premium valuation (P/E 61.1) and execution of growth initiatives. Strong institutional interest, such as Bank of New York Mellon's $78.77 million investment, supports confidence in the stock's trajectory.
WMB trades at $75.83, up 2.27% today, with a bullish technical outlook supported by moving averages and strong analyst consensus. The company reported mixed Q2 2026 earnings but maintains robust profitability with a 25.18% net income margin. Recent developments include the $5.5 billion acquisition of Momentum Midstream, enhancing its natural gas infrastructure, while a court ruling vacated a key permit for the NESE pipeline project.
The stock offers growth exposure to natural gas demand driven by LNG exports and AI infrastructure, with a consensus price target of $88.14 implying 16% upside. Risks include regulatory hurdles for pipeline projects and high debt levels, but strong cash flow supports dividends and expansion.
Trailing returns across standard periods
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →